![Seppo Ylä-Herttuala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seppo Ylä-Herttuala
Corporate Officer/Principal bij University of Kuopio
Actieve functies van Seppo Ylä-Herttuala
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Kuopio | Corporate Officer/Principal | 24-11-2010 | - |
Loopbaan van Seppo Ylä-Herttuala
Eerdere bekende functies van Seppo Ylä-Herttuala
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 11-09-2009 | 15-03-2013 |
Oprichter | 11-09-2009 | 15-03-2013 | |
Corporate Officer/Principal | 11-09-2009 | 15-03-2013 | |
FinVector Oy
![]() FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Oprichter | 01-01-1993 | - |
Opleiding van Seppo Ylä-Herttuala
University of Tampere | Doctorate Degree |
Statistieken
Internationaal
Finland | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
FinVector Oy
![]() FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
- Beurs
- Insiders
- Seppo Ylä-Herttuala
- Ervaring